Search

everythinglearnresearchcommunity

for

Search:↓

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

More research is needed on CCCA in children, especially Black and Asian adolescents.

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

CCCA can affect both genders and all ages, and it has a genetic component.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Chemical relaxers may cause scarring alopecia in black women.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Some women with common hair loss may develop permanent hair loss.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.